Noninvasive modulation of the hippocampal-entorhinal complex during spatial navigation in humans.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
Nov 2024
Historique:
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: ppublish

Résumé

Because of the depth of the hippocampal-entorhinal complex (HC-EC) in the brain, understanding of its role in spatial navigation via neuromodulation was limited in humans. Here, we aimed to better elucidate this relationship in healthy volunteers, using transcranial temporal interference electric stimulation (tTIS), a noninvasive technique allowing to selectively neuromodulate deep brain structures. We applied tTIS to the right HC-EC in either continuous or intermittent theta-burst stimulation patterns (cTBS or iTBS), compared to a control condition, during a virtual reality-based spatial navigation task and concomitant functional magnetic resonance imaging. iTBS improved spatial navigation performance, correlated with hippocampal activity modulation, and decreased grid cell-like activity in EC. Collectively, these data provide the evidence that human HC-EC activity can be directly and noninvasively modulated leading to changes of spatial navigation behavior. These findings suggest promising perspectives for patients suffering from cognitive impairment such as following traumatic brain injury or dementia.

Identifiants

pubmed: 39475597
doi: 10.1126/sciadv.ado4103
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eado4103

Auteurs

Elena Beanato (E)

Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), Clinique Romande de Réadaptation, École Polytechnique Fédérale de Lausanne (EPFL Valais), Sion, Switzerland.

Hyuk-June Moon (HJ)

Laboratory of Cognitive Neuroscience, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Center for Bionics, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, South Korea.

Fabienne Windel (F)

Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), Clinique Romande de Réadaptation, École Polytechnique Fédérale de Lausanne (EPFL Valais), Sion, Switzerland.

Pierre Vassiliadis (P)

Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), Clinique Romande de Réadaptation, École Polytechnique Fédérale de Lausanne (EPFL Valais), Sion, Switzerland.

Maximillian J Wessel (MJ)

Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), Clinique Romande de Réadaptation, École Polytechnique Fédérale de Lausanne (EPFL Valais), Sion, Switzerland.
Department of Neurology, University Hospital Würzburg, Würzburg, Germany.

Traian Popa (T)

Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), Clinique Romande de Réadaptation, École Polytechnique Fédérale de Lausanne (EPFL Valais), Sion, Switzerland.
Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Menoud Pauline (M)

Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), Clinique Romande de Réadaptation, École Polytechnique Fédérale de Lausanne (EPFL Valais), Sion, Switzerland.

Esra Neufeld (E)

Foundation for Research on Information Technologies in Society (IT'IS), Zurich, Switzerland.
ZMT Zurich MedTech AG, Zurich, Switzerland.

Emanuela De Falco (E)

Laboratory of Cognitive Neuroscience, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.

Baptiste Gauthier (B)

Laboratory of Cognitive Neuroscience, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.

Melanie Steiner (M)

Foundation for Research on Information Technologies in Society (IT'IS), Zurich, Switzerland.

Olaf Blanke (O)

Laboratory of Cognitive Neuroscience, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Department of Clinical Neuroscience, University of Geneva Medical School, Geneva, Switzerland.

Friedhelm C Hummel (FC)

Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), École Polytechnique Fédérale de Lausanne (EPFL), Geneva, Switzerland.
Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX), Clinique Romande de Réadaptation, École Polytechnique Fédérale de Lausanne (EPFL Valais), Sion, Switzerland.
Department of Clinical Neuroscience, University of Geneva Medical School, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH